TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 1.4B
Gross Profit 180.6M 13.34%
Operating Income 112.7M 8.33%
Net Income 74.7M 5.52%
EPS (Diluted) $0.44

Balance Sheet Metrics

Total Assets 5.6B
Total Liabilities 3.6B
Shareholders Equity 2.0B
Debt to Equity 1.81

Cash Flow Metrics

Operating Cash Flow 129.4M
Free Cash Flow 62.0M

Revenue & Profitability Trend

Select Medical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i5.2B6.7B6.3B6.2B5.5B
Cost of Goods Sold i4.6B5.7B5.6B5.3B4.7B
Gross Profit i633.6M932.0M733.4M919.4M821.3M
Gross Margin % i12.2%14.0%11.6%14.8%14.8%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i225.9M170.2M153.0M147.0M138.0M
Other Operating Expenses i-3.4M-1.8M-28.8M-144.0M-90.0M
Total Operating Expenses i222.5M168.4M124.3M2.9M48.0M
Operating Income i268.3M554.9M403.3M713.8M567.7M
Operating Margin % i5.2%8.3%6.4%11.5%10.3%
Non-Operating Items
Interest Income i-005.4M0
Interest Expense i128.6M198.6M169.1M136.0M153.0M
Other Non-Operating Income35.1M26.1M26.4M46.6M41.8M
Pre-tax Income i174.8M382.4M260.6M629.7M456.5M
Income Tax i44.8M82.6M62.6M129.8M111.9M
Effective Tax Rate % i25.6%21.6%24.0%20.6%24.5%
Net Income i296.7M299.7M198.0M499.9M344.6M
Net Margin % i5.7%4.5%3.1%8.1%6.2%
Key Metrics
EBITDA i536.1M804.4M635.5M966.2M802.8M
EPS (Basic) i$1.66$1.91$1.23$2.98$1.93
EPS (Diluted) i$1.66$1.91$1.23$2.98$1.93
Basic Shares Outstanding i124628000123105000122511000130249000129780000
Diluted Shares Outstanding i124628000123105000122511000130249000129780000

Income Statement Trend

Select Medical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i59.7M84.0M97.9M74.3M577.1M
Short-term Investments i059.0M74.9M0-
Accounts Receivable i821.4M940.3M941.3M889.3M896.8M
Inventory i-----
Other Current Assets112.1M151.6M125.4M120.2M114.5M
Total Current Assets i1.0B1.3B1.3B1.1B1.6B
Non-Current Assets
Property, Plant & Equipment i908.1M1.2B1.2B1.1B1.0B
Goodwill i4.8B7.4B7.3B7.3B7.1B
Intangible Assets i103.2M329.9M351.7M374.9M387.5M
Long-term Investments-----
Other Non-Current Assets372.8M376.7M341.7M338.7M319.2M
Total Non-Current Assets i4.6B6.4B6.4B6.2B6.1B
Total Assets i5.6B7.7B7.7B7.4B7.7B
Liabilities
Current Liabilities
Accounts Payable i142.2M174.3M186.7M233.8M177.1M
Short-term Debt i225.7M346.0M313.1M289.3M233.0M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i977.7M1.2B1.2B1.3B1.4B
Non-Current Liabilities
Long-term Debt i2.5B4.6B4.8B4.5B4.3B
Deferred Tax Liabilities i81.5M143.3M169.8M142.8M132.4M
Other Non-Current Liabilities73.0M110.3M106.1M106.4M168.7M
Total Non-Current Liabilities i2.6B4.9B5.1B4.7B4.6B
Total Liabilities i3.6B6.1B6.3B6.0B6.0B
Equity
Common Stock i129.0K128.0K127.0K134.0K135.0K
Retained Earnings i770.1M751.9M581.0M593.3M553.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.0B1.6B1.4B1.4B1.7B
Key Metrics
Total Debt i2.7B5.0B5.2B4.8B4.5B
Working Capital i42.1M9.2M116.2M-133.6M155.6M

Balance Sheet Composition

Select Medical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i296.7M299.7M198.0M499.9M344.6M
Depreciation & Amortization i203.9M208.7M205.8M202.6M205.7M
Stock-Based Compensation i100.7M43.8M37.8M30.9M27.2M
Working Capital Changes i-81.6M-24.6M-172.4M-256.8M310.3M
Operating Cash Flow i490.2M514.2M279.0M484.0M875.2M
Investing Activities
Capital Expenditures i-222.2M-229.2M-190.4M-180.5M-146.4M
Acquisitions i-13.1M-39.4M-44.3M-102.9M-52.2M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-231.0M-268.5M-226.3M-256.6M-115.4M
Financing Activities
Share Repurchases i-37.9M-12.8M-195.5M-79.5M-16.0M
Dividends Paid i-64.6M-63.9M-64.6M-50.6M0
Debt Issuance i4.3B3.0B1.1B193.0M40.1M
Debt Repayment i-4.8B-3.2B-881.0M-39.7M-558.2M
Financing Cash Flow i-315.6M-329.2M-45.3M-647.4M-1.1B
Free Cash Flow i295.7M352.9M94.5M220.7M881.6M
Net Change in Cash i-56.5M-83.4M7.4M-420.0M-381.7M

Cash Flow Trend

Select Medical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.21
Forward P/E 6.37
Price to Book 1.07
Price to Sales 0.35
PEG Ratio 6.37

Profitability Ratios

Profit Margin 3.33%
Operating Margin 8.33%
Return on Equity 7.72%
Return on Assets 2.42%

Financial Health

Current Ratio 1.16
Debt to Equity 136.22
Beta 1.20

Per Share Data

EPS (TTM) $0.62
Book Value per Share $13.40
Revenue per Share $41.69

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
sem1.8B23.211.077.72%3.33%136.22
HCA Healthcare 94.2B16.91-76.8113,631.68%8.21%-37.45
Tenet Healthcare 15.7B11.184.2029.65%7.18%158.70
Acadia Healthcare 1.9B13.800.624.83%4.31%74.74
Pacs 1.8B19.413.15110.96%2.59%469.36
Ardent Health 1.8B6.571.4424.32%4.11%138.17

Financial data is updated regularly. All figures are in the company's reporting currency.